Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
34 Cards in this Set
- Front
- Back
blockade of alpha receptors in smooth muscle
|
results in
-reduced peripheral resistance and BP |
|
alpha antagonist given with epinephrine:
|
epinephrine reversal in which a1 vasoconstriction is blocked and B2 vasodilation is unopposed
fall in resistance and BP instead of inc of BP normally seen. |
|
a antagonists on heart
|
inc in heart rate bc of:
-reflex in response to dec bc of alpha antagonist -blockage of a2 presynaptic receptors which normally dec NE release |
|
a1 antagonists on veins
|
orthostatic hypotension
|
|
alpha antagonist list
|
tamsulosin, prazosin, terazosin, doxazosin a1>>>a2
phenoxybenzamine a1>a2 Phentolamine a1=a2 rauwolscine, yohimbine, tolazoline a2>>>a1 |
|
Phentolamine
|
potent reversible competetive non selective alpha antagonist
manage hypertensive crisis (surgery for phaeochromocytoma) net effect: inc C.O., vasodilation, no change in BP. |
|
Phenoxybenzamine
|
irreversible a adrenergic receptor antagonist, a1>a2
|
|
Prazosin
Doxazosin Terazosin |
highly selective antagonist of a1 adrenoreceptors
relieve symptoms of urinary obstruction in benign prostatic hyperplasia and hypertension in raynaud's syndrome |
|
tamsulosin
|
a1 selective antagonist-
higher selectivity for relieving urinary retention in benign prostatic hyperplasia might be preferred if patient has experienced postural hypotension, but if patient has comorbid hypertension then use zosins |
|
yohimbine
|
a2 selective adrenoceptor antagonist - no clinical use
|
|
propanolol
|
prototypical beta blocker
non selective agent clinically for hypertension, major effect of B-blockers is on heart to dec hypertension |
|
labetolol and carvedilol
|
block a1 and B receptors
|
|
In people who are normotensive, taking a beta agonist will result in
|
nothing- reduces hr in hypertension- does not cause hypotension in normotensive people.
|
|
Chronic use of B-blockers results in
|
total resistance returning to initial values in presence of hypertension
delayed fall in peripheral resistance and persistent reduction of CO accounts for antihyypertensive action for these drugs |
|
beta blockers and CV system
|
supraventricular arrhythmias and ventricular arrhytmias
acute M.I. heart failure angina (improves relationship of cardiac oxygen supply and demand) |
|
beta blockers and respiratory system
|
propanolol block B2 receptors in the bronchial smooth muscle
-can lead to lethal bronchoconstriction in persons with asthma or COPD |
|
Beta blockers and metabolic effects
|
B1 selective agents in patients with diabetes are preferable
B2 antagonist will block tachycardia (warning sign) and glycolysis and gluconeogenesis |
|
beta blockers and the eye
|
dec in production of aq humor by pilocarpine and timolol for glaucoma
|
|
carvedilol
|
also a1 antagonist,
|
|
labetalol
|
nonselective b antagonist
a1 antagonist b1 antagonist partial agonist B2 can cause orthostatic hypertension |
|
partial agonist
|
labetalol
penbutolol pindolol acebutalol (b1 selective) celiprolol (b1 selective) |
|
nadolol
|
non selective b blocker
longest acting |
|
timolol
|
non selective b blocker
use with pilocarpine for open angle glaucoma |
|
penbutolol
|
non selective b blocker
partial agonist |
|
pindolol
|
non selective b blocker
partial agonist |
|
acebutolol
|
b1 selective blocker, partial agonist,
|
|
atenolol
|
b1 selective blocker
longer hl then others in class |
|
celiprolol
|
b1 selective partial agonist
b1 antagonist and b2 agonist |
|
esmolol
|
b1 selective blocker, lasts 10 minutes
-used in critically ill patients sensitive to bradycardia |
|
metoprolol
|
b1 selective blocker, widely used
|
|
b-blocker and hyperthyroidism
|
excessive catecholamine activity causes tachycardia and heart failure
b blockers can be used to control this |
|
b blocker and migraines
|
can reduce frequency and intensity but do not prevent or stop when it has already started
|
|
b blockers and cv adverse effect
|
caution of use in people with CHF, can reverse adverse affects with isoproterenol
|
|
indirect adrenergic receptor antagonists
|
-blocks release of catecholamines
-reserpine- drop in BP and cardiac rate- effects persist for days -guanethidine- drug blocks release of NE- gradual lowering of BP and HR -Metyrosine |